Compare ISTR & MOBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISTR | MOBI |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.5M | 383.0M |
| IPO Year | 2014 | 2026 |
| Metric | ISTR | MOBI |
|---|---|---|
| Price | $30.15 | $10.72 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $31.50 | N/A |
| AVG Volume (30 Days) | ★ 113.3K | 98.5K |
| Earning Date | 04-20-2026 | N/A |
| Dividend Yield | ★ 1.59% | N/A |
| EPS Growth | ★ 4.41 | N/A |
| EPS | ★ 1.38 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $66.56 | N/A |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $21.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.43 | $10.34 |
| 52 Week High | $31.27 | $15.19 |
| Indicator | ISTR | MOBI |
|---|---|---|
| Relative Strength Index (RSI) | 53.42 | 41.09 |
| Support Level | $28.75 | $10.73 |
| Resistance Level | $30.53 | $11.61 |
| Average True Range (ATR) | 0.50 | 1.00 |
| MACD | -0.05 | -0.07 |
| Stochastic Oscillator | 51.98 | 16.69 |
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashier's checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The company develops, markets and sells devices for the treatment of medical conditions. Its flagship device is the Vivistim Paired Vagus Nerve Stimulation system, which is used to support motor function rehabilitation in patients with chronic ischemic stroke. The company generates all of its revenue from the sale of the Vivistim System to customers, mainly primary and comprehensive stroke centers, in the United States.